Talk to John about these topics and more:

• Tactics for driving health innovation
• Optimizing market access strategies for new therapies
• Demonstrating value through HEOR
• Drug development life cycle strategies

Talk to Tara about these topics and more: 

• Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
• Best practices in clinical data science and biometrics operations
• Clinical trial design and interim analysis
• Biostatistical consulting and regulatory interaction

Talk to Jay about these topics and more:

• Understanding cardiac safety requirements, including protocol design 
• Sponsor support at FDA meetings 
• Early phase development 
• Working with data and safety monitoring boards 
• Cardiac arrhythmias and electrophysiology